Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #14,381 to #14,430.
- (hist) Vaginal cancer case study one [326 bytes]
- (hist) Sheehan's syndrome case study one [326 bytes]
- (hist) Hyperaldosteronism MRI [326 bytes]
- (hist) Hemolytic-uremic syndrome case study one [326 bytes]
- (hist) Hemolytic-uremic syndrome cost-effectiveness of therapy [326 bytes]
- (hist) Kasabach-Merritt syndrome case study one [326 bytes]
- (hist) Kasabach-Merritt syndrome future or investigational therapies [326 bytes]
- (hist) Kasabach-Merritt syndrome cost-effectiveness of therapy [326 bytes]
- (hist) Kasabach-Merritt syndrome history and symptoms [326 bytes]
- (hist) Kasabach-Merritt syndrome physical examination [326 bytes]
- (hist) Kasabach-Merritt syndrome historical perspective [326 bytes]
- (hist) Kasabach-Merritt syndrome differential diagnosis [326 bytes]
- (hist) Kasabach-Merritt syndrome epidemiology and demographics [326 bytes]
- (hist) Kasabach-Merritt syndrome causes [326 bytes]
- (hist) Pernicious anemia case study one [326 bytes]
- (hist) Pernicious anemia future or investigational therapies [326 bytes]
- (hist) Pernicious anemia cost-effectiveness of therapy [326 bytes]
- (hist) Pernicious anemia surgery [326 bytes]
- (hist) Pernicious anemia other diagnostic studies [326 bytes]
- (hist) Pernicious anemia other imaging findings [326 bytes]
- (hist) Pernicious anemia screening [326 bytes]
- (hist) Pernicious anemia epidemiology and demographics [326 bytes]
- (hist) Pernicious anemia differential diagnosis [326 bytes]
- (hist) Pernicious anemia classification [326 bytes]
- (hist) Diffuse panbronchiolitis differential diagnosis [326 bytes]
- (hist) Fungal pneumonia risk factors [326 bytes]
- (hist) Fungal pneumonia history and symptoms [326 bytes]
- (hist) Fungal pneumonia physical examination [326 bytes]
- (hist) Fungal pneumonia laboratory findings [326 bytes]
- (hist) Focal segmental glomerulosclerosis secondary prevention [326 bytes]
- (hist) Focal segmental glomerulosclerosis cost-effectiveness of therapy [326 bytes]
- (hist) Focal segmental glomerulosclerosis future or investigational therapies [326 bytes]
- (hist) Focal segmental glomerulosclerosis case study one [326 bytes]
- (hist) Drug-induced lupus erythematosus electrocardiogram [326 bytes]
- (hist) Campylobacteriosis historical perspective [326 bytes]
- (hist) Campylobacteriosis physical examination [326 bytes]
- (hist) Campylobacteriosis other diagnostic studies [326 bytes]
- (hist) Campylobacteriosis secondary prevention [326 bytes]
- (hist) Campylobacteriosis cost-effectiveness of therapy [326 bytes]
- (hist) Campylobacteriosis future or investigational therapies [326 bytes]
- (hist) Campylobacteriosis case study one [326 bytes]
- (hist) Chikungunya case study one [326 bytes]
- (hist) Legionellosis case study one [326 bytes]
- (hist) Legionellosis future or investigational therapies [326 bytes]
- (hist) Legionellosis cost-effectiveness of therapy [326 bytes]
- (hist) Subdural hematoma case study one [326 bytes]
- (hist) Subdural hematoma future or investigational therapies [326 bytes]
- (hist) Subdural hematoma cost-effectiveness of therapy [326 bytes]
- (hist) Subdural hematoma other diagnostic studies [326 bytes]
- (hist) Subdural hematoma other imaging findings [326 bytes]